Steve G. Robison

4.7k total citations · 1 hit paper
27 papers, 717 citations indexed

About

Steve G. Robison is a scholar working on Epidemiology, Health and Microbiology. According to data from OpenAlex, Steve G. Robison has authored 27 papers receiving a total of 717 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Epidemiology, 18 papers in Health and 6 papers in Microbiology. Recurrent topics in Steve G. Robison's work include Vaccine Coverage and Hesitancy (18 papers), Influenza Virus Research Studies (12 papers) and Pneumonia and Respiratory Infections (6 papers). Steve G. Robison is often cited by papers focused on Vaccine Coverage and Hesitancy (18 papers), Influenza Virus Research Studies (12 papers) and Pneumonia and Respiratory Infections (6 papers). Steve G. Robison collaborates with scholars based in United States, United Kingdom and Switzerland. Steve G. Robison's co-authors include James A. Gaudino, Holly C. Groom, Juventila Liko, Paul R. Cieslak, Linda Sheldon, Harold Zenick, Larry L. Needham, Nancy G. Doerrer, Richard J. Albertini and Michael G. Bird and has published in prestigious journals such as SHILAP Revista de lepidopterología, PEDIATRICS and Clinical Infectious Diseases.

In The Last Decade

Steve G. Robison

25 papers receiving 681 citations

Hit Papers

Impact of the COVID-19 Pandemic on Administration of Sele... 2021 2026 2022 2024 2021 40 80 120

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Steve G. Robison United States 14 353 295 139 134 68 27 717
Michiel Luteijn United Kingdom 17 81 0.2× 204 0.7× 35 0.3× 139 1.0× 10 0.1× 24 779
Jane Oliver Australia 17 86 0.2× 203 0.7× 23 0.2× 390 2.9× 8 0.1× 52 794
Tracey Goodman Switzerland 14 211 0.6× 236 0.8× 12 0.1× 140 1.0× 16 0.2× 20 655
K Uemura Switzerland 14 105 0.3× 147 0.5× 26 0.2× 165 1.2× 11 0.2× 26 1.0k
Anand Zachariah India 17 14 0.0× 116 0.4× 119 0.9× 184 1.4× 6 0.1× 66 886
Ayalew Astatkie Ethiopia 16 75 0.2× 176 0.6× 9 0.1× 127 0.9× 13 0.2× 55 727
Jenaro Astray Spain 20 191 0.5× 537 1.8× 101 0.7× 239 1.8× 19 0.3× 53 923
Iain Blair United Arab Emirates 16 31 0.1× 87 0.3× 27 0.2× 260 1.9× 11 0.2× 28 772
Andrea Cambieri Italy 13 91 0.3× 126 0.4× 28 0.2× 101 0.8× 11 0.2× 40 413

Countries citing papers authored by Steve G. Robison

Since Specialization
Citations

This map shows the geographic impact of Steve G. Robison's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steve G. Robison with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steve G. Robison more than expected).

Fields of papers citing papers by Steve G. Robison

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Steve G. Robison. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steve G. Robison. The network helps show where Steve G. Robison may publish in the future.

Co-authorship network of co-authors of Steve G. Robison

This figure shows the co-authorship network connecting the top 25 collaborators of Steve G. Robison. A scholar is included among the top collaborators of Steve G. Robison based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Steve G. Robison. Steve G. Robison is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Murthy, Bhavini Patel, Elizabeth R. Zell, Nkenge Jones-Jack, et al.. (2024). Impact of the COVID-19 pandemic on routine childhood vaccination in 9 U.S. jurisdictions. Vaccine. 42(22). 125997–125997. 12 indexed citations
2.
Dombkowski, Kevin J., et al.. (2024). Implications of the COVID-19 Pandemic on IIS Operations, Performance, and Future Readiness: Not the New Normal. Journal of Public Health Management and Practice. 30(2). 155–157.
4.
Hatch, Brigit, Paul M. Darden, Lyle J. Fagnan, et al.. (2022). Clinic‐level differences in human papillomavirus vaccination rates among rural and urban Oregon primary care clinics. The Journal of Rural Health. 39(2). 499–507. 2 indexed citations
5.
Kirtland, Karen A., Elizabeth R. Zell, Nkenge Jones-Jack, et al.. (2021). Influenza Vaccinations During the COVID-19 Pandemic — 11 U.S. Jurisdictions, September–December 2020. MMWR Morbidity and Mortality Weekly Report. 70(45). 1575–1578. 24 indexed citations
6.
Robison, Steve G.. (2020). The Impact of the Number of Injections per Visit on the Likelihood of Human Papillomavirus Immunization. SHILAP Revista de lepidopterología. 3. 100024–100024. 1 indexed citations
8.
Liko, Juventila, Steve G. Robison, & Paul R. Cieslak. (2017). Do Pertussis Vaccines Protect Against Bordetella parapertussis?. Clinical Infectious Diseases. 64(12). 1795–1797. 15 indexed citations
9.
Robison, Steve G. & Juventila Liko. (2017). The Timing of Pertussis Cases in Unvaccinated Children in an Outbreak Year: Oregon 2012. The Journal of Pediatrics. 183. 159–163. 14 indexed citations
10.
Safford, B., A.M. Api, Christopher L. R. Barratt, et al.. (2017). Application of the expanded Creme RIFM consumer exposure model to fragrance ingredients in cosmetic, personal care and air care products. Regulatory Toxicology and Pharmacology. 86. 148–156. 31 indexed citations
11.
Robison, Steve G., et al.. (2017). Changes in Influenza Vaccination Rates After Withdrawal of Live Vaccine. PEDIATRICS. 140(5). 5 indexed citations
12.
Robison, Steve G., et al.. (2017). The Concordance of Parent and Child Immunization. PEDIATRICS. 139(5). 20 indexed citations
13.
Safford, B., A.M. Api, Christopher L. R. Barratt, et al.. (2015). Use of an aggregate exposure model to estimate consumer exposure to fragrance ingredients in personal care and cosmetic products. Regulatory Toxicology and Pharmacology. 72(3). 673–682. 61 indexed citations
14.
Robison, Steve G., Juventila Liko, & Paul R. Cieslak. (2015). Differences in Pertussis Incidence by Income among Oregon Teens during an Outbreak. 2015. 1–4. 4 indexed citations
15.
Liko, Juventila, Steve G. Robison, & Paul R. Cieslak. (2014). Pertussis Vaccine Performance in an Epidemic Year--Oregon, 2012. Clinical Infectious Diseases. 59(2). 261–263. 28 indexed citations
16.
Robison, Steve G.. (2013). Sick-Visit Immunizations and Delayed Well-Baby Visits. PEDIATRICS. 132(1). 44–48. 7 indexed citations
19.
Blackburn, Karen, Donald L. Bjerke, George P. Daston, et al.. (2011). Case studies to test: A framework for using structural, reactivity, metabolic and physicochemical similarity to evaluate the suitability of analogs for SAR-based toxicological assessments. Regulatory Toxicology and Pharmacology. 60(1). 120–135. 45 indexed citations
20.
Albertini, Richard J., Michael G. Bird, Nancy G. Doerrer, et al.. (2006). The Use of Biomonitoring Data in Exposure and Human Health Risk Assessments. Environmental Health Perspectives. 114(11). 1755–1762. 95 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026